|
Market Closed -
Nasdaq
16:00:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -5.26% |
|
-18.71% | -82.31% |
| 08-26 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 08-24 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
EPS & Dividend: Scinai Immunotherapeutics Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -402 | -2,833 | -400 | -166.4 | -35.58 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 2,810.000 | 2,350.000 | 296.000 | 59.540 | 7.121 |
| Nbr of stocks (in thousands) | 11.5 | 18.5 | 34.9 | 43.5 | 347 |
| Announcement Date | 5/13/21 | 3/28/22 | 4/17/23 | 5/15/24 | 4/1/26 |
1USD in Million2USD
Estimates
Past dividends: Scinai Immunotherapeutics Ltd.
| 2026-08-21 | Significant Split/Dividend | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.37% | 1.5% | 21.73x | 5.12x | 7.71x | |
| 0.04% | 0.09% | 29.82x | 5.88x | 8.57x | |
| 0.98% | 1.13% | 32.98x | 4.47x | 5.93x | |
| -.--% | -.--% | -21.31x | 22.39x | 230.81x | |
| -.--% | -.--% | 33.26x | 6.18x | 3.23x | |
| -.--% | -.--% | 46.77x | 7.65x | 5.41x | |
| 0.41% | 0.43% | 27.63x | 2.23x | 7.93x | |
| -.--% | -.--% | 32.99x | 3.46x | 7.05x | |
| -.--% | -.--% | -15.1x | 1.24x | 5.68x | |
| Average | 0.31% | 0.35% | 20.98x | 6.51x | 31.37x | |
| Weighted average by Cap. | 0.42% | 0.47% | 22.27x | 6.90x | 32.04x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
